Colombian National Health Observatory, Instituto Nacional de Salud, Bogotá, DC, Colombia; Department of Health Sciences, Universidad de la Costa, Barranquilla, Colombia; Department of Epidemiology, School of Public Health, University of São Paulo, São Paulo, SP, Brazil.
Salud MIA EPS - Oficina basada en Valor Fundación Cardiovascular de Colombia, Bucaramanga, Colombia.
Value Health Reg Issues. 2022 Sep;31:127-133. doi: 10.1016/j.vhri.2022.04.005. Epub 2022 Jun 4.
This study aimed to estimate the direct medical costs due to hospitalizations by COVID-19 in Colombia and to identify their cost drivers in Colombia.
This is a retrospective cost-of-illness study of COVID-19 in Colombia. We estimated direct medical costs using data from patients insured to a Benefit Plan Administrator Company, between March 15, 2020 and May 29, 2020. Absolute and relative frequencies, averages, medians, and interquartile ranges (IQRs) were used to characterize the population and estimate the costs of hospitalized patients with COVID-19. We stratified the cost analysis by sex, age groups, comorbidities, and type of hospitalization (general ward and intensive care unit [ICU]). Cost drivers were calculated from a generalized linear model.
We studied 113 confirmed patients, 51.3% men. On average, the hospital length of stay was 7.3 (± 6.2) days. A person hospitalized with COVID-19 reported median costs of $1688 (IQR 788-2523). In women, this cost was $1328 (IQR 463-2098); in men, this was 1.4 times greater. The median cost for ICU was $4118 (IQR 2069-5455), 3 times higher than those hospitalized only in the general ward. Admission to the ICU, having 1 comorbidity, length of stay, high blood pressure, having 5 comorbidities, and being treated in the city of Cartagena were statistically significant with direct medical costs.
Our study provides an idea of the magnitude of costs needed to hospitalize a COVID-19 case in Colombia. Other studies in Colombia have assessed the costs of hospitalization for infectious diseases such as influenza, costs significantly lower than those described here.
本研究旨在估计哥伦比亚因 COVID-19 住院导致的直接医疗费用，并确定其在哥伦比亚的成本驱动因素。
这是一项在哥伦比亚进行的 COVID-19 疾病成本研究。我们使用 2020 年 3 月 15 日至 2020 年 5 月 29 日期间参保Benefit Plan Administrator Company 的患者数据来估算直接医疗费用。使用绝对和相对频率、平均值、中位数和四分位距（IQR）来描述人群并估算 COVID-19 住院患者的费用。我们按性别、年龄组、合并症和住院类型（普通病房和重症监护病房[ICU]）对成本分析进行分层。成本驱动因素是从广义线性模型中计算得出的。
我们研究了 113 名确诊患者，其中 51.3%为男性。平均而言，住院时间为 7.3（±6.2）天。COVID-19 住院患者的报告中位数费用为 1688 美元（IQR 788-2523）。女性的费用为 1328 美元（IQR 463-2098）；男性则高出 1.4 倍。入住 ICU 的中位数费用为 4118 美元（IQR 2069-5455），是仅在普通病房住院患者的 3 倍。入住 ICU、存在 1 种合并症、住院时间、高血压、存在 5 种合并症以及在卡塔赫纳市接受治疗与直接医疗费用具有统计学意义。
本研究提供了一个概念，即哥伦比亚每例 COVID-19 住院病例所需的费用规模。哥伦比亚的其他研究评估了流感等传染病的住院费用，其费用明显低于此处描述的费用。
